Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane

Biochemistry

Volumn 45, Issue 29, 2006, Pages 8751-8759

  Dziedzicka Wasylewska, Marta ^a   Faron Górecka, Agata ^a   Andrecka, Joanna ^b   Polit, Agnieszka ^b   Kuśmider, Maciej ^a   Wasylewski, Zygmunt ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGICAL MEMBRANES; DIMERIZATION; ELECTROPHYSIOLOGY; ENERGY TRANSFER; FLUORESCENCE; MICROSCOPIC EXAMINATION; OLIGOMERS;

DOPAMINE; FÖRSTER RESONANCE ENERGY TRANSFER (FRET); HETERODIMERIZATION; PROTEIN-COUPLED RECEPTORS;

PROTEINS;

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COMPLEMENTARY DNA; CYAN FLUORESCENT PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR; QUINPIROLE; RADIOLIGAND; SPIPERONE; TRITIUM; YELLOW FLUORESCENT PROTEIN;

ARTICLE; CELL MEMBRANE; CELL STRAIN HEK293; CONFOCAL MICROSCOPY; DOPAMINERGIC SYSTEM; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; LIGAND BINDING; OLIGOMERIZATION; PRIORITY JOURNAL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; CELL LINE; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GREEN FLUORESCENT PROTEINS; HUMANS; MICROSCOPY, CONFOCAL; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SPECTROMETRY, FLUORESCENCE; SPIPERONE;

EID: 33746220118     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi060702m     Document Type: Article

References (49)

1. Milligan, G., and Bouvier, M. (2005) Methods to monitor the quaternary structure of G protein-coupled receptors, FEBS Lett. 272, 2914-2925.
2. Franco, R., Canals, M., Marcellino, D., Ferré, S., Agnati, L., Mallol, J., Casadó, V., Ciurella, F., Fuxe, K., Llius, C., and Canela, E. I. (2003) Regulation of heptaspanning-membrane-receptor function by dimerization and clustering, Trends Biochem. Sci. 28, 238-243.
3. Hebert, T. E., and Bouvier, M. (1998) Structural and functional aspects of G protein-coupled receptor oligomerization, Biochem. Cell Biol. 76, 1-11.
4. Lavine, N., Ethier, N., Oak, J. N., Pei, L., Liu, F., Trieu, P., Rebois, R. V., Bouvier, M., Hebert, T. E., and Van Tol, H. H. (2002) G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase, J. Biol. Chem. 277, 46010-46019.
5. Agnati, L. F., Ferre, S., Lluis, C., Franco, R., and Fuxe, K. (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons, Pharmacol Rev. 55, 509-550.
6. Emilien, G., Maloteaux, J. M., Geurts, M., Hoogenberg, K., and Cragg, S. (1999) Dopamine receptors: Physiological understanding to therapeutic intervention potential, Pharmacol. Toxicol. 84, 133-156.
7. Stoof, J. C., and Kebabian, J. W. (1984) Two dopamine receptors: Biochemistry, physiology and pharmacology, Life Sci. 35, 2281-2296.
8. Missale, C. X., Nash, S. R., Robinson, S. W., Jabber, M., and Caron, M. G. (1998) Dopamine receptors: From structure to function, Physiol. Rev. 78, 189-225.
9. Ng, G. Y., O'Dowd, B. F., Lee, S. P., Chung, H. T., Brann, M. R., Seeman, P., and George, S. R. (1996) Dopamine D2 receptor dimers and receptor-blocking peptides, Biochem. Biophys. Res. Commun. 227, 200-204.
10. Nimchinsky, E. A., Hof, P. R., Janssen, W. G. M., Morrison, J. H., and Schmauss, C. (1997) Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells, J. Biol. Chem. 272, 29229-29237.
11. George, S. R., Lee, S. P., Varghose, G., Zeman, P. R., Seeman, P., Ng, G. K. Y., and O'Dowd, B. F. (1998) A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization, J. Biol. Chem. 273, 30244-30248.
12. Zawarynski, P., Tallerico, T., Seeman, V., Lee, S. P., O'Dowd, B. F., and George, S. R. (1998) Dopamine D2 receptor dimers in human and rat brain, FEBS Lett. 441, 383-386.
13. Scarselli, M., Novi, F., Schallmach, E., Liu, R., Baragli, A., Colzi, A., Griffon, N., Corsini, G. U., Sokoloff, P., Levenson, R., Vogel, Z., and Maggio, R. (2001) D2/D3 dopamine receptor heterodimers exhibit unique functional properties, J. Biol. Chem. 276, 30308-30314.
14. Ginés, S., Hillion, J., Torvinen, M., Le Crom, S., Casado, V., Canela, E. I., Rondin, S., Lew, J. Y., Watson, S., Zoli, M., Agnati, L. F., Verniere, P., Lluis, C., Ferre, S., Fuxe, K., and Franco, R. (2000) Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes Proc. Natl. Acad. Sci. U.S.A. 97, 8606-8611.
15. Hillion, J., Canals, M., Torvinen, M., Casado, V., Scott, R., Terasmaa, A., Hansson, A., Watson, S., Olah, M. E., Mallol, J., Canela, E. I., Zoli, M., Agnati, L. F., Ibanez, C. F., Lluis, L., Franco, R., Ferre, S., and Fuxe, K. (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors, J. Biol. Chem. 277, 18091-18097.
16. Franco, R., Ferre, S., Agnati, L. F., Torvinen, M., Gines, S., Hillion, J., Casado, V., Lledo, P., Zoli, M., Lluis, C., and Fuxe, K. (2000) Evidence for adenosine/dopamine receptor interactions: Indications for heteromerization, Neuropsychopharmacology 23 (Suppl. 4), S50-S59.
17. Salim, H., Ferre, S., Dalal, A., Peterfreund, R. A., Fuxe, K., Vincent, J. D., and Lledo, P. M. (2000) Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells, J. Neurochem. 74, 432-439.
18. Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., and Patel, Y. C. (2000) Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity, Science 288, 154-157.
19. Liu, F., Wan, Q., Pristupa, Z. B., Yu, X. M., Wang, Y. T., and Niznik, H. B. (2000) Direct protein-protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors, Nature 403, 274-280.
20. Fiorentini, C., Gardoni, F., Spano, P., Di Luca, M., and Missale, C. (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate W-methyl-D-aspartate receptors, J. Biol. Chem. 278, 20196-20202.
21. Pei, L., Lee, F. J. S., Moszczynska, A., Vukusic, B., and Liu, F. (2004) Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors, J. Neurosci. 24, 1149-1158.
22. Lewis, M. H., Widerlov, E., Knoght, D. L., Kilts, C. D., and Mailman, R. B. (1983) N-Oxides of phenothiazine antipsychotics: Effects on in vivo and in vitro estimates of dopaminergic function, J. Pharmacol. Exp. Ther. 225, 539-545.
23. Mailman, R. B., Schulz, D. W., Lewis, M. H., Staples, L., Rollema, H., and Dehaven, D. L. (1984) SCH-23390: A selective D1 dopamine antagonist with potent D2 behavioral actions, Eur. J. Pharmacol. 101, 159-160.
24. White, F. J., Bednarz, L. M., Wachtel, S. R., Hjorth, S., and Brooderson, R. J. (1988) Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol. Biochem. Behav. 30, 189-193.
25. Ikemoto, S., Glazier, B. S., Murphy, J. M., and McBride, W. J. (1997) Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward, J. Neurosci. 17, 8580-8587.
26. Imperato, A., and Di Chiara, G. (1988) Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis, Eur. J. Pharmacol. 156, 385-393.
27. Pan, H. S., Engber, T. M., Chase, T. N., and Walters, J. R. (1990) The effects of striatal lesion on turning behavior and globus pallidus single unit response to dopamine agonist administration, Life Sci. 46, 73-80.
28. Walters, J. R., Bergstrom, D. A., Carlson, J. H., Chase, T. N., and Braun, A. R. (1987) D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects, Science 236, 719-722.
29. LaHoste, G. J., and Marshall, F. F. (1996) Dopamine, in CNS Neurotransmitters and Neuromodulators (Stone, T. W., Ed.) pp 107-119, CRC Press Inc., Boca Raton, FL.
30. LaHoste, G. J., Yu, J., and Marshall, J. F., (1993) Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity, Proc. Natl. Acad. Sci. U.S.A. 90, 7451-7455.
31. LaHoste, G. J., Henry, B. L., and Marshall, J. F. (2000) Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials, J. Neurosci. 20, 6666-6671.
32. Gerfen, C. R. (2000) Molecular effects of dopamine on striatal-projection pathways, Trends Neurosci. 23 (Suppl.), S64-S70.
33. Ariano, M. A., Larson, E. R., and Noblett, K. L. (1995) in Molecular and Cellular Mechanisms of Neostriatal Function (Ariano, M. A., and Surmeier, D. J., Eds.) pp 59-70, Landes, Austin, TX.
34. Lester, J., Fink, S., Aronin, N., and DiFiglia, M. (1993) Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons, Brain Res. 621, 106-110.
35. Surmeier, D. J., Eberwine, J., Wilson, C. J., Cao, Y., Stefani, A., and Kitai, S. T. (1992) Dopamine receptor subtypes colocalize in rat striatonigral neurons, Proc. Natl. Acad. Sci. U.S.A. 89, 10178-10182.
36. Aizman, O., Brismar, H., Uhlén, P., Zettergren, E., Levey, A. I., Forssberg, H., Greengard, P., and Aperia, A. (2000) Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons, Nat. Neurosci. 3, 226-230.
37. Surmeier, D. J., Song, W.-J., and Yan, Z. (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons, J. Neurosci. 16, 6579-6591.
38. Lee, S. P., So, C. H., Rashid, A. J., Varghese, G., Cheng, R., Lanca, A. J., O'Dowd, B. F., and George, S. R. (2004) Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal, J. Biol. Chem. 279, 35671-35678.
39. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1996) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Plainview, NY.
40. Mercier, J. F., Salahpour, A., Angers, S., Breit, A., and Bouvier, M. (2002) Quantitative assessment of β1- and β2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer, J. Biol. Chem. 277, 44925-44931.
41. Dinger, M. C., Bader, J. E., Kobor, A. D., Kretzschmar, A. K., and Beck-Sickinger, A. G. (2003) Homodimerization of neuropeptide Y receptors by fluorescence resonance energy transfer in living cells, J. Biol. Chem. 278, 10562-10571.
42. Breit, A., Lagace, M., and Bouvier, M. (2004) Hetero-oligomerization between β2- and β3-adrenergic receptors generates a β-adrenergic signaling unit with distinct functional properties, J. Biol. Chem. 279, 28756-28765.
43. Berney, C., and Danuser, G. (2003) FRET or no FRET: A quantitative comparison, Biophys. J. 84, 3992-4010.
44. Ayoub, M. A., Couturier, C., Lucas-Meunier, E., Angers, S., Possier, P., Bouvier, M., and Jockers, R. (2002) Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence energy transfer, J. Biol. Chem. 277, 21522-21528.
45. Stanasila, L., Perez, J. B., Vogel, H., and Cotecchia, S. (2003) Oligomerization of the α1a- and α1b-adrenergic receptor subtypes. Potential implications in receptor internalization, J. Biol. Chem. 278, 40239-40251.
46. O'Dowd, B. F., Ji, X., Alijaniaram, M., Rajaram, R. D., Kong, M. M., Rashid, A., Nguyen, T., and George, S. R. (2005) Dopamine receptor oligomerization visualized in living cells, J. Biol. Chem. 280, 37225-37235.
47. So, C. H., Varghese, G., Curley, K. J., Kong, M. M. C., Alijaniaram, M., Ji, X., Nguyen, T., O'Dowd, B. F., and George, S. R. (2005) D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor, Mol. Pharmacol. 68, 568-578.
48. Pfleger, K. D., and Eidne, K. A. (2005) Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells, Biochem. J. 385, 625-637.
49. Maggio, R., Scarselli, M., Novi, F., Millan, M. J., and Corsini, G. U. (2003) Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole, J. Neurochem. 87, 631-641.